Dihydroergotamine (injection): Difference between revisions
Line 79: | Line 79: | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
'''Dihydroergotamine''' is an [[ergot]] alkaloid used to treat [[migraine]]s.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a24befa8-b952-48ac-942a-379585250782 | publisher = | date = | accessdate = }}</ref> | '''Dihydroergotamine''' is an [[ergot]] alkaloid used to treat [[migraine]]s.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = MIGRANAL (DIHYDROERGOTAMINE MESYLATE) SPRAY [VALEANT PHARMACEUTICALS INTERNATIONAL] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a24befa8-b952-48ac-942a-379585250782 | publisher = | date = | accessdate = }}</ref> <ref>{{Cite web | last = | first = | title = D.H.E. 45 (DIHYDROERGOTAMINE MESYLATE) INJECTION, SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe826e6a-75c8-43ed-9c36-f8263ec35aff | publisher = | date = | accessdate = }}</ref> | ||
<ref>{{Cite web | last = | first = | title = D.H.E. 45 (DIHYDROERGOTAMINE MESYLATE) INJECTION, SOLUTION [VALEANT PHARMACEUTICALS NORTH AMERICA] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fe826e6a-75c8-43ed-9c36-f8263ec35aff | publisher = | date = | accessdate = }}</ref> | |||
==References== | ==References== |
Revision as of 22:49, 11 February 2014
Dihydroergotamine |
---|
MIGRANAL (dihydroergotamine mesylate) spray® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Dosage Forms and Strengths |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Dihydroergotamine |
ClinicalTrials.gov |
Dihydroergotamine |
D.H.E. 45 (dihydroergotamine mesylate) injection, solution® FDA Package Insert |
Indications and Usage |
Dosage and Administration |
Dosage Forms and Strengths |
Contraindications |
Warnings and Precautions |
Adverse Reactions |
Drug Interactions |
Use in Specific Populations |
Overdosage |
Description |
Clinical Pharmacology |
Nonclinical Toxicology |
Clinical Studies |
How Supplied/Storage and Handling |
Patient Counseling Information |
Labels and Packages |
Clinical Trials on Dihydroergotamine |
ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Pratik Bahekar, MBBS [2]
For patient information about Dihydroergotamine, click here.
Synonyms / Brand Names: MIGRANAL (dihydroergotamine mesylate) spray®, D.H.E. 45®, DIHYDROERGOTAMINE MESYLATE injection®
Overview
Clinical data | |
---|---|
ATC code | |
Pharmacokinetic data | |
Elimination half-life | 9 hours |
Identifiers | |
CAS Number | |
PubChem CID | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C33H37N5O5 |
Molar mass | 583.678 g/mol |
Dihydroergotamine is an ergot alkaloid used to treat migraines.
Category
FDA Package Insert
MIGRANAL (dihydroergotamine mesylate) spray
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
D.H.E. 45 (dihydroergotamine mesylate) injection, solution
Indications and Usage | Dosage and Administration | Dosage Forms and Strengths | Contraindications | Warnings and Precautions | Adverse Reactions | Drug Interactions | Use in Specific Populations | Overdosage | Description | Clinical Pharmacology | Nonclinical Toxicology | Clinical Studies | How Supplied/Storage and Handling | Patient Counseling Information | Labels and Packages
Mechanism of Action
Dihydroergotamine is an ergot alkaloid used to treat migraines.[1] [2]
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs
- Lysergamides